Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines
- 15 April 1986
- journal article
- research article
- Published by Elsevier BV in Cellular Immunology
- Vol. 99 (1), 196-208
- https://doi.org/10.1016/0008-8749(86)90228-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The proliferative immune response to autologous Epstein-Barr virus-transformed lymphoblastoid cells. I. Studies with HLA haplotype loss variants demonstrate a role for MHC-linked genesHuman Immunology, 1985
- Antigen-specific interaction between T and B cellsNature, 1985
- Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigensHuman Immunology, 1984
- Antigen presentation by resting B cells. Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation.The Journal of Experimental Medicine, 1984
- Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell lineHuman Immunology, 1983
- Antigen-specific human T-lymphocyte clones Genetic restriction of influenza virus-specific responses to HLA-D region genesHuman Immunology, 1982
- Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells.The Journal of Experimental Medicine, 1981
- HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cellsNature, 1980
- Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicityNature, 1979
- Assay of the Infectivity of Epstein-Barr Virus by Transformation of Human Leucocytes in vitroJournal of General Virology, 1972